King Charles’s Health Sparks Fresh Questions After Absence From Royal Ballet School Anniversary
King Charles has prompted fresh questions about his health after missing the Royal Ballet School’s 100th anniversary celebrations, with his absence fuelling speculation about a possible change to the monarch’s demanding royal schedule.
The King, who serves as patron of the Royal Ballet School, was notably absent from the milestone event, according to a report by Page Six. His non-attendance attracted attention because of his longstanding connection to the institution.
Instead, Lady Sarah Chatto, the daughter of the late Princess Margaret, was reported to have represented the monarchy at the celebrations.
Lady Sarah has a close association with the world of ballet, serving as president of both the Royal Ballet School and Birmingham Royal Ballet, making her appearance at the anniversary particularly fitting.
Nevertheless, Charles’s absence has prompted renewed discussion about whether the monarch is adjusting his public commitments while continuing his cancer treatment.
The King has remained visible at a number of engagements during 2026, demonstrating that he has continued to carry out official duties despite the health challenges he disclosed publicly in 2024.
His recent programme has included a high-profile visit to the United States, while a Caribbean tour has also been announced, underlining the continued demands of his role as head of state.
These appearances have helped maintain the King’s public presence, but they have also placed his schedule under scrutiny whenever an expected engagement passes without him.
According to the Page Six report, questions have emerged about claims that the monarch’s official calendar is being quietly reduced. However, the report does not establish that the King’s absence from the ballet anniversary was caused by a deterioration in his health.
Buckingham Palace announced on February 5, 2024, that Charles had been diagnosed with cancer and would undergo treatment. The Palace has not publicly identified the type of cancer.
Since that announcement, the King has continued to undertake public duties while receiving treatment, although his programme has been subject to adjustments at different points.
For a monarch with a packed schedule of ceremonies, meetings and overseas engagements, individual absences can prompt speculation. However, one missed event alone cannot establish that his health has worsened or that a broader reduction in duties is under way.
Lady Sarah’s appearance also illustrates how other members of the Royal Family can represent royal institutions at important occasions when the monarch is not present.
The Royal Ballet School’s centenary was a significant milestone for the organisation, and its president’s attendance ensured that the institution’s royal connection remained visible.
For now, Charles’s absence has raised questions rather than provided answers. Without a confirmed explanation from the Palace, it remains unclear whether the decision reflected scheduling considerations, health-related precautions or another reason.
The King’s health will inevitably remain a subject of public interest while he continues treatment, but any suggestion that his condition has worsened should be treated cautiously unless supported by an official update or reliable evidence.
